Abstract
Oral mucositis is a severe and frequently dose-limiting side effect of radio(chemo)therapy for head and neck tumours. Keratinocyte Growth Factor, synthesized mainly by mesenchymal cells, predominantly modulates epithelial proliferation and differentiation processes. A significant reduction of radiation-induced oral mucosal reactions by recombinant human Keratinocyte Growth Factor (Palifermin) has been demonstrated in a number of experimental studies and in clinical investigations. The underlying mechanisms, however, currently remain unclear.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
